Qube Research & Technologies (QRT)
INM icon

Qube Research & Technologies (QRT)’s InMed Pharmaceuticals INM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio INM Stock Details INM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10
Closed -$54 – 3697
2024
Q2 		$54 Hold
10
– – ﹤0.01% 3498
2024
Q1 		$70 Hold
10
– – ﹤0.01% 4200
2023
Q4 		$83 Buy
+10
New +$97 ﹤0.01% 4038

Other funds holding INM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Qube Research & Technologies (QRT)'s INM Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of InMed Pharmaceuticals (INM) in Q3 2024, closing a stake of 10 shares — an estimated $54 sold.

Qube Research & Technologies (QRT) first reported a position in INM in Q4 2023 and held it in 3 quarters. The position peaked at $83 in Q4 2023. 13 funds tracked by Wall St. Rank hold INM as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining InMed Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 10 InMed Pharmaceuticals shares in Q3 2024, an estimated $54.
  • Qube Research & Technologies (QRT) first reported a position in InMed Pharmaceuticals in Q4 2023 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s InMed Pharmaceuticals position peaked at $83 in Q4 2023.
  • 13 funds tracked by Wall St. Rank held InMed Pharmaceuticals as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.